Schellenberg Wittmer has advised Bioventure Club Deal Nine & Co KG on a Series B Financing Round of the Swiss Aphaia Companies, which are clinical stage pharma companies that have developed proprietary treatment methods targeting
Tags :Laura Roth
Perfect Holding announced the completion of the reverse takeover transaction (RTO) with Kinarus, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of viral, respiratory, and ophthalmic disease.
Kinarus, a privately owned clinical-stage biopharmaceutical company active in the development of novel treatments for patients suffering from serious viral, respiratory and ophthalmic diseases, signed a Transaction Agreement with SIX-listed Perfect Holding regarding Perfect Holding’
Arsenal Capital Partners, a global private equity firm focusing on franchises in the healthcare and industrial sectors, has completes its acquisition of ATP Group from Bregal Unternehmerkapital. Swiss headquartered ATP Group is a manufacturer of
On 27 January 2022, Liechtensteinische Landesbank (LLB), 74.9%-majority shareholder of Bank Linth LLB, has published the pre-announcement for a public tender offer to acquire all of the outstanding shares of Bank Linth. LLB will offer Bank Linth
